Hence, it has been shown that loss of SMAD4 alters BMP signaling and promotes CRC metastases via activation of Rho and ROCK pathways, leading BMP signaling to switch from tumor suppressive to metastasis-promoting function [91]. The gene discussed is SMAD4; the disease is colorectal carcinoma.